Lotus Pharmaceutical Co., Ltd. (1795.TW)
TWD 260.5
(-1.14%)
TWD 260.5
(-1.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 16.95 Billion | 14.63 Billion | 12.64 Billion | 10.72 Billion | 9.17 Billion | 6.42 Billion |
| Cost of Revenue | 8.61 Billion | 6.82 Billion | 7 Billion | 6.13 Billion | 4.92 Billion | 3.28 Billion |
| Gross Profit | 8.33 Billion | 7.8 Billion | 5.64 Billion | 4.59 Billion | 4.24 Billion | 3.13 Billion |
| Operating Expenses | 4.48 Billion | 3.69 Billion | 3.31 Billion | 2.98 Billion | 3.13 Billion | 2.69 Billion |
| Selling, General and Administrative Expenses | 2.71 Billion | 3.17 Billion | 2.71 Billion | 2.47 Billion | 2.58 Billion | 2.36 Billion |
| Research and Development Expenses | 720.82 Million | 520.44 Million | 595.92 Million | 505.37 Million | 553.56 Million | 324.93 Million |
| Other Expenses | - | 208.05 Million | -133.91 Million | 17.81 Million | 102.76 Million | 34.74 Million |
| Cost and Expenses | 12.05 Billion | 10.52 Billion | 10.31 Billion | 9.11 Billion | 8.06 Billion | 5.98 Billion |
| Operating Income | 4.9 Billion | 4.31 Billion | 2.2 Billion | 1.63 Billion | 1.21 Billion | 448.68 Million |
| Interest Expense | 557.39 Million | 382.46 Million | 296.83 Million | 333.78 Million | 338.81 Million | 320 Million |
| Income Tax Expense | 997.29 Million | 919.45 Million | 466.64 Million | 274.58 Million | 198.13 Million | 39.61 Million |
| Earnings before Tax | 5.1 Billion | 3.94 Billion | 1.87 Billion | 1.3 Billion | 876.42 Million | 163.7 Million |
| Net Income | 4.1 Billion | 3.02 Billion | 1.4 Billion | 1.02 Billion | 662.8 Million | 99.47 Million |
| Earnings Per Share Basic | 15.72 | 11.59 | 5.50 | 4.23 | 3.11 | 0.42 |
| Earnings Per Share Diluted | 15.67 | 11.54 | 5.47 | 4.23 | 3.11 | 0.42 |
| Weighted Average Shares Outstanding | 261.17 Million | 260.54 Million | 255.17 Million | 243.11 Million | 241.9 Million | 238.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 262.02 Million | 261.68 Million | 256.68 Million | 243.47 Million | 241.9 Million | 238.2 Million |
| Gross Margin | 0.49 | 0.53 | 0.45 | 0.43 | 0.46 | 0.49 |
| EBIT Margin | 0.41 | 0.36 | 0.23 | 0.22 | 0.20 | 0.14 |
| Profit Margin | 0.24 | 0.21 | 0.11 | 0.10 | 0.07 | 0.02 |
| EBITDA | 6.87 Billion | 5.25 Billion | 2.92 Billion | 2.34 Billion | 1.91 Billion | 874.96 Million |
| Earnings Before Tax Margin | 0.29 | 0.30 | 0.17 | 0.15 | 0.13 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.74 Billion | 4.19 Billion | 16.95 Billion | 3.41 Billion | 4.57 Billion | 4.44 Billion |
| Cost of Revenue | 2.12 Billion | 1.89 Billion | 8.61 Billion | 2.26 Billion | 1.92 Billion | 1.83 Billion |
| Gross Profit | 2.62 Billion | 2.3 Billion | 8.33 Billion | 1.14 Billion | 2.64 Billion | 2.6 Billion |
| Operating Expenses | 987.29 Million | 1.04 Billion | 3.43 Billion | 1 Billion | 1.17 Billion | 992.61 Million |
| Selling, General and Administrative Expenses | 764.33 Million | 931.81 Million | - | 814.25 Million | 935.51 Million | 863.89 Million |
| Research and Development Expenses | 222.95 Million | 116.97 Million | - | 191.91 Million | 235.16 Million | 128.72 Million |
| Other Expenses | 143.66 Million | 179.97 Million | 725.83 Million | 507.61 Million | 209.63 Million | 40.89 Million |
| Cost and Expenses | 3.1 Billion | 2.94 Billion | 12.05 Billion | 3.27 Billion | 3.09 Billion | 2.82 Billion |
| Operating Income | 1.63 Billion | 1.45 Billion | 4.9 Billion | 143.39 Million | 1.69 Billion | 1.65 Billion |
| Interest Expense | 138.73 Million | 151.31 Million | 557.39 Million | 157.75 Million | 136.1 Million | 135.38 Million |
| Income Tax Expense | 329.4 Million | 270.05 Million | 997.29 Million | 108.23 Million | 320.39 Million | 258.02 Million |
| Earnings before Tax | 1.66 Billion | 1.3 Billion | 5.1 Billion | 508.18 Million | 1.56 Billion | 1.52 Billion |
| Net Income | 1.33 Billion | 1.03 Billion | 4.1 Billion | 399.95 Million | 1.24 Billion | 1.26 Billion |
| Earnings Per Share Basic | 5.09 | 3.96 | - | 1.51 | 4.76 | 4.85 |
| Earnings Per Share Diluted | 5.06 | 3.94 | - | 1.51 | 4.75 | 4.84 |
| Weighted Average Shares Outstanding | 261.6 Million | 261.69 Million | 261.24 Million | 264.46 Million | 261.48 Million | 261.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 263.25 Million | 263.01 Million | 262.02 Million | 264.46 Million | 262.11 Million | 261.58 Million |
| Gross Margin | 0.55 | 0.55 | 0.49 | 0.34 | 0.58 | 0.59 |
| EBIT Margin | 0.41 | 0.42 | - | 0.14 | 0.44 | 0.44 |
| Profit Margin | 0.28 | 0.25 | 0.24 | 0.12 | 0.27 | 0.28 |
| EBITDA | 1.94 Billion | 1.77 Billion | - | 466.46 Million | 1.98 Billion | 1.95 Billion |
| Earnings Before Tax Margin | 0.34 | 0.35 | 0.29 | 0.04 | 0.37 | 0.37 |
TRENT
AMRUTANJAN
4222
SXTP
REDINGTON
1619